← FDA Drug Approvals (Drugs@FDA)
ERLOTINIB HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2020-07-02
Drug application
- FDA Application #
ANDA211083- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Generic name
- Erlotinib Hydrochloride
- Active ingredients
- ERLOTINIB HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2020-07-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown